Eurobio Scientific : Rapport Financier Semestriel 2020

16 October 2020 - 17:35


Pièce jointe

Provided by: GlobeNewswire
Euronext Growth Paris (France)
The Eurobio scientific group, resulting from the acquisition by Exonhit of Ingen in 2012 and Eurobio in 2017, is a French fully integrated leader in the field of in-vitro diagnostics with expertise ranging from discovery to commercialization of specialty diagnostic solutions as well as products for research in life-science....
Learn more about company

Related news

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date